Catalyst Wire Dossier Catalyst Wire Dossier

0.3% sodium hyaluronate

sodium hyaluronate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 0.3% sodium hyaluronate, covering 2016-01-12 to 2016-01-12. Get the full timeline:

Most recent: Clinical Trial Update: 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients [Phase 4]

See pricing